Cite
APA Citation
Chen, I., Hu, F., Lin, C., Huang, S., Chang, D., Cheng, A., & Lu, Y. (2021). anti-HER2 antibody prolongs overall survival disproportionally more than progression-free survival in HER2-Positive metastatic breast cancer patients. Breast, 59, 211–220. http://access.bl.uk/ark:/81055/vdc_100142213016.0x00002f